The Rationale Behind the Therapeutic Potential of Drugs Containing Hydroxycinnamic Acid on Hepatocellular Cancer Induced by 4-Dimethylaminoazobenzene: Technique-Related Implications
Ebrahim, S., Elmetwalli, A., Abu El-Magd, M., El-Naggar, S., Salama, A. (2022). The Rationale Behind the Therapeutic Potential of Drugs Containing Hydroxycinnamic Acid on Hepatocellular Cancer Induced by 4-Dimethylaminoazobenzene: Technique-Related Implications. EKB Journal Management System, 14(2), 13-23. doi: 10.21608/eajbsd.2022.253527
Shimaa Mustafa Ebrahim; Alaa Elmetwalli; Mohammed Abu El-Magd; Sabry Ali El-Naggar; Afrah Fatthi Salama. "The Rationale Behind the Therapeutic Potential of Drugs Containing Hydroxycinnamic Acid on Hepatocellular Cancer Induced by 4-Dimethylaminoazobenzene: Technique-Related Implications". EKB Journal Management System, 14, 2, 2022, 13-23. doi: 10.21608/eajbsd.2022.253527
Ebrahim, S., Elmetwalli, A., Abu El-Magd, M., El-Naggar, S., Salama, A. (2022). 'The Rationale Behind the Therapeutic Potential of Drugs Containing Hydroxycinnamic Acid on Hepatocellular Cancer Induced by 4-Dimethylaminoazobenzene: Technique-Related Implications', EKB Journal Management System, 14(2), pp. 13-23. doi: 10.21608/eajbsd.2022.253527
Ebrahim, S., Elmetwalli, A., Abu El-Magd, M., El-Naggar, S., Salama, A. The Rationale Behind the Therapeutic Potential of Drugs Containing Hydroxycinnamic Acid on Hepatocellular Cancer Induced by 4-Dimethylaminoazobenzene: Technique-Related Implications. EKB Journal Management System, 2022; 14(2): 13-23. doi: 10.21608/eajbsd.2022.253527